Status:
COMPLETED
Rapid, Onsite COVID-19 Detection
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Institutes of Health (NIH)
AIDS Vaccine Research Lab
Conditions:
COVID-19
Sars-CoV2
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
The purpose of this research study is to evaluate and improve a rapid COVID-19 test. The test is designed to identify people who are most contagious and likely to spread the virus to others. This test...
Detailed Description
Virtually all COVID-19 RNA assays require centralized laboratories. Samples collected in locations including public testing sites, workplaces, nursing homes, and residential housing are transported to...
Eligibility Criteria
Inclusion
- Willing to provide informed consent
- Willing to provide informed consent and spit into a vessel
- Individuals at least 5 years of age and have a parent or legal guardian present to consent if under 18 years
- Adult participants must have decision-making capacity to provide consent on their own behalf.
- Participants must be able to speak English
Exclusion
- Under 18 years of age with no parent or legal guardian present or under the age of 5 yrs
- Participants must not have visual or hearing impairments, or low literacy, that would prevent them from reading the consent form and interacting with a member of the research team to ask questions and receive responses during the consent process
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT04460690
Start Date
July 13 2020
End Date
March 31 2021
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53711